Filter News
Area of Research
- (-) Isotopes (3)
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Environment (45)
- Clean Energy (101)
- Climate and Environmental Systems (4)
- Computational Biology (1)
- Computational Engineering (3)
- Computer Science (7)
- Electricity and Smart Grid (1)
- Fusion and Fission (4)
- Materials (54)
- Materials for Computing (15)
- Mathematics (1)
- National Security (8)
- Neutron Science (60)
- Nuclear Science and Technology (4)
- Quantum information Science (3)
- Sensors and Controls (1)
- Supercomputing (45)
- Transportation Systems (2)
News Type
Media Contacts
![Summer Widner, Stephanie Timbs, James Gaugler and James Avenell of ORNL are part of a team that processes thorium-228, a byproduct of actinium-227. As new uses for thorium are realized, particularly in medicine, the lab expects the demand for the radioisotope to grow.](/sites/default/files/styles/list_page_thumbnail/public/2021-08/Part%20of%20Th-228%20Team_1.jpg?h=09b6d1d3&itok=1_l1hx2l)
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
![Targeted alpha therapy can deliver radiation to specific cells, with minimal effect on surrounding, healthy cells. Credit: Michelle Lehman and Jaimee Janiga/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/gif_high_res.gif?h=ae1281eb&itok=QtNBjm3O)
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
![Sandra Davern performs cell based assays to evaluate cell death and DNA damage in response to radiation in order to gain a better understanding of how radioisotope nanoparticles affect the human body.](/sites/default/files/styles/list_page_thumbnail/public/2020-10/2020-P15712.jpg?h=036a71b7&itok=6cpxN4v2)
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.